AlphaMaven AlphaMaven

Blackstone inks $1.5bn sale of ZO Skin Health to Galderma

Reported by Pehub ·Alternativeswatch
Oct 14, 2026· 1 min read
Save Post LinkedIn Email
Key Takeaways
  • • Blackstone has agreed to sell ZO Skin Health to Galderma in a transaction valued at $1.5bn.
  • • ZO Skin Health, founded by dermatologist Zein Obagi, generated about $330m in net sales in the 12 months to June.
  • • The skincare brand sells more than 40 products across more than 40 countries.
Summary
Blackstone has agreed to sell ZO Skin Health to Galderma for $1.5bn, according to the original report. The deal represents a notable exit for Blackstone from a dermatology-focused skincare platform.

ZO Skin Health was founded by dermatologist Zein Obagi and generated about $330m in net sales in the 12 months to June. The company sells more than 40 products in over 40 countries, positioning it as a meaningful international player in professional skincare.

The transaction gives Galderma, a dermatology and aesthetics company, a larger footprint in physician-recommended skincare. For institutional investors, the sale implies an enterprise value of roughly 4.5 times trailing net sales, based on the reported figures.

The source article is limited in detail beyond these headline terms, and further information on deal structure, timing and closing conditions was not available in the primary source.

Go deeper than the headline

Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.

Start your free 7-day trial

Sources

2 outlets

AlphaMaven summarised this story from the reporting below. Each link opens the original article.

Pehub Blackstone inks $1.5bn sale of ZO Skin Health to Galderma Alternativeswatch Blackstone to exit ZO Skin Health in $1.5bn sale to Galderma